PTPRF and ovarian cancer: In ovarian cancer cells down-regulation of VIM expression resulted in resistance to cisplatin by potentially down-regulating its import and up-regulating its export, indicating that it might also be contributing to cisplatin resistance in the LAR subtype [64].